You've seen the headline: CA-AKG reversed biological age by eight years.
The study is real. The number is real. And almost every page repeating it leaves out the detail that determines how much weight it should carry.
Let's go through it properly, because a compound with a genuinely interesting mechanism is being undersold by overselling.
What Alpha-Ketoglutarate Does
AKG sits at the centre of the citric acid cycle — the sequence of reactions inside mitochondria that extracts energy from fuel. It's a metabolic hub, not a peripheral molecule.
It has roles beyond energy. AKG is the obligatory co-substrate for a family of dioxygenase enzymes including the TET enzymes, which mediate DNA demethylation, and the JmjC histone demethylases. These are epigenetic regulators — proteins that determine which genes are read in which cells. That's the mechanistic basis for the interest in AKG and biological ageing, and it's a legitimate one. Mechanism
Circulating AKG declines substantially with age. One frequently cited analysis found a roughly tenfold decrease between ages 40 and 80.
The Animal Evidence
Asadi Shahmirzadi and colleagues (2020), in Cell Metabolism, gave calcium AKG to mice starting in mid-life. Treated animals showed reduced frailty and a modest extension of lifespan — but the more striking result was the effect on healthspan: the treated mice spent a substantially larger proportion of their remaining life in good health, compressing the period of decline at the end. Preclinical
That healthspan-versus-lifespan distinction is the genuinely interesting finding, and it's the one that gets dropped in favour of the sexier number.
Now the Human Study — Read Carefully
Demidenko and colleagues (2021), in Aging, reported on 42 people taking a calcium-AKG-based formulation, with DNA methylation age assessed using the TruMe methylation clock. Average methylation age was reported approximately eight years lower than at baseline. Human, uncontrolled
Here is what that study was not:
- There was no placebo group. No control arm means no way to separate the intervention's effect from regression to the mean, seasonal variation, or the lifestyle changes people typically make when they start a longevity protocol and know they're being measured.
- It was not blinded. Participants knew what they were taking.
- The sample was 42 people, self-selected — the kind of person who buys a longevity supplement and pays for methylation testing is not a random sample of anyone.
- The formulation contained other ingredients. Attribution to AKG alone isn't clean.
- Methylation clocks have real measurement variance. Different clocks disagree with each other on the same sample, and test-retest variability on some is substantial.
None of this makes the result worthless. It makes it a pilot study generating a hypothesis worth testing properly — which is exactly how the authors framed it, and exactly how the marketing does not.
A randomised, placebo-controlled trial is needed. A 2022 review noted that recent human studies had not demonstrated an anti-aging role for AKG and called for further clinical research. Until controlled results are published, the methylation finding remains hypothesis-generating rather than evidence that CA-AKG reverses biological age.
Why the Calcium Salt Form
Free alpha-ketoglutaric acid is unstable and degrades quickly in the acidic environment of the stomach. Binding it to calcium produces a stable salt with a slower release profile, surviving gastric transit for absorption further along. This is also the form used in the published research — CA-AKG, not free AKG.
Note that CA-AKG contributes meaningful elemental calcium at typical doses. Factor that into your total intake if you already supplement calcium.
What It's Reasonable to Expect
| Outcome | Evidence level | Honest read |
|---|---|---|
| Reduced frailty in ageing | Mouse, mid-life onset | Well-conducted animal work |
| Healthspan compression | Mouse | The most interesting finding |
| Methylation age reduction | Uncontrolled human pilot, n=42 | Hypothesis-generating only |
| Ammonia buffering | Mechanistic + sports literature | Plausible, not conclusive |
| Bone density support | Limited human data | Preliminary |
CA-AKG is included in the Longevity Complex™ at a researched dose alongside compounds acting on complementary pathways. It's a rational component of a broad protocol — not, on current evidence, a standalone age-reversal intervention.
The mechanism is real. The animal data is good. The human data is preliminary. That combination is worth taking seriously and worth describing accurately, and both of those things can be true at once.
See CA-AKG →References
Asadi Shahmirzadi A, et al. Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice. Cell Metab. 2020;32(3):447–456. Preclinical
Demidenko O, et al. Rejuvant®, a formulation with alpha-ketoglutarate and vitamins, and changes in a DNA methylation test. Aging (Albany NY). 2021;13(22):24485–24499. Human, uncontrolled pilot
Gyanwali B, et al. Alpha-Ketoglutarate dietary supplementation to improve health in humans. Trends Endocrinol Metab. 2022;33(2):136–146. Evidence review
These statements have not been evaluated by the Food and Drug Administration. Not intended to diagnose, treat, cure or prevent any disease. The biological age findings described come from an uncontrolled pilot study and should not be interpreted as demonstrating an effect. Consult a qualified healthcare professional before use.
